GeneDx Holdings Corp. Depreciation and Amortization
GeneDx Holdings Corp. (WGS) reported Depreciation and Amortization of $3.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-08-03
- GeneDx Holdings Corp. depreciation, depletion and amortization for the quarter ending 2026-06-30 was $3.10M, a 34.78% increase year-over-year.
- GeneDx Holdings Corp. depreciation, depletion and amortization for the quarter ending 2026-03-31 was $2.70M, a 22.73% increase year-over-year.
- GeneDx Holdings Corp. depreciation, depletion and amortization for the quarter ending 2025-12-31 was $2.77M, a 36.96% increase year-over-year.
- GeneDx Holdings Corp. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $2.37M, a 2.15% decline year-over-year.
- GeneDx Holdings Corp. depreciation, depletion and amortization for fiscal 2025 was $9.60M, a 21.52% increase from fiscal 2024.
- GeneDx Holdings Corp. depreciation, depletion and amortization for fiscal 2024 was $7.90M, a 59.90% decline from fiscal 2023.
- GeneDx Holdings Corp. depreciation, depletion and amortization for fiscal 2023 was $19.70M, a 60.60% decline from fiscal 2022.
- GeneDx Holdings Corp. depreciation, depletion and amortization for fiscal 2022 was $50.00M, a 129.28% increase from fiscal 2021.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 3 month as first filed | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 6 month as first filed | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month | Depreciation, Depletion and Amortization 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.10M 10-Q · filed 2026-08-03 | $5.80M 10-Q · filed 2026-08-03 | $8.57M derived: sum of 3 quarters · filed 2026-08-03 | $10.94M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2026-03-31 | $2.70M 10-Q · filed 2026-05-04 | $5.47M derived: sum of 2 quarters · filed 2026-05-04 | $7.84M derived: sum of 3 quarters · filed 2026-05-04 | $10.14M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $5.14M derived: sum of 2 quarters · filed 2026-02-23 | $7.44M derived: sum of 3 quarters · filed 2026-08-03 | $9.60M 10-K · filed 2026-02-23 | |||
| 2025-09-30 | $2.37M 10-Q · filed 2025-10-28 | $4.67M derived: sum of 2 quarters · filed 2026-08-03 | $6.83M 10-Q · filed 2025-10-28 | $8.89M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-06-30 | $2.30M 10-Q · filed 2026-08-03 | $2.29M 10-Q · filed 2025-07-29 | $4.50M 10-Q · filed 2026-08-03 | $4.46M 10-Q · filed 2025-07-29 | $6.52M derived: sum of 3 quarters · filed 2026-08-03 | $8.95M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-03-31 | $2.20M 10-Q · filed 2026-05-04 | $2.17M 10-Q · filed 2025-04-30 | $4.22M derived: sum of 2 quarters · filed 2026-05-04 | $6.65M derived: sum of 3 quarters · filed 2026-05-04 | $8.36M derived: sum of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $4.45M derived: sum of 2 quarters · filed 2026-02-23 | $6.16M derived: sum of 3 quarters · filed 2026-02-23 | $7.90M 10-K · filed 2026-02-23 | |||
| 2024-09-30 | $2.42M 10-Q · filed 2025-10-28 | $4.13M derived: sum of 2 quarters · filed 2025-10-28 | $5.88M 10-Q · filed 2025-10-28 | $8.45M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2024-06-30 | $1.71M 10-Q · filed 2025-07-29 | $3.45M 10-Q · filed 2025-07-29 | $6.03M derived: sum of 3 quarters · filed 2026-02-23 | $11.20M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2024-03-31 | $1.74M 10-Q · filed 2025-04-30 | $4.32M derived: sum of 2 quarters · filed 2026-02-23 | $9.49M derived: sum of 3 quarters · filed 2026-02-23 | $16.31M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2023-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $7.74M derived: sum of 2 quarters · filed 2026-02-23 | $14.57M derived: sum of 3 quarters · filed 2026-02-23 | $19.70M 10-K · filed 2026-02-23 | |||
| 2023-09-30 | $5.17M 10-Q · filed 2024-10-29 | $11.99M derived: sum of 2 quarters · filed 2024-10-29 | $17.12M 10-Q · filed 2024-10-29 | $47.70M derived: sum of 4 quarters · filed 2024-10-29 | |||
| 2023-06-30 | $6.83M 10-Q · filed 2024-07-30 | $11.96M 10-Q · filed 2024-07-30 | $42.53M derived: sum of 3 quarters · filed 2024-07-30 | $49.53M derived: sum of 4 quarters · filed 2024-07-30 | |||
| 2023-03-31 | $5.13M 10-Q · filed 2024-04-29 | $35.70M derived: sum of 2 quarters · filed 2024-04-29 | $42.70M derived: sum of 3 quarters · filed 2024-04-29 | $49.33M derived: sum of 4 quarters · filed 2024-04-29 | |||
| 2022-12-31 | $30.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $37.57M derived: sum of 2 quarters · filed 2024-02-23 | $44.20M derived: sum of 3 quarters · filed 2024-02-23 | $50.00M 10-K · filed 2024-02-23 | $59.31M 10-K · filed 2023-03-16 | ||
| 2022-09-30 | $7.00M 10-Q · filed 2023-11-03 | $13.62M derived: sum of 2 quarters · filed 2023-11-03 | $19.43M 10-Q · filed 2023-11-03 | $25.22M derived: sum of 4 quarters · filed 2023-11-03 | |||
| 2022-06-30 | $6.63M 10-Q · filed 2023-08-08 | $12.43M 10-Q · filed 2023-08-08 | $18.23M derived: sum of 3 quarters · filed 2023-08-08 | $23.72M derived: sum of 4 quarters · filed 2023-08-08 | |||
| 2022-03-31 | $5.80M 10-Q · filed 2023-05-09 | $11.60M derived: sum of 2 quarters · filed 2023-05-09 | $17.09M derived: sum of 3 quarters · filed 2023-05-09 | $22.71M derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | $5.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $11.29M derived: sum of 2 quarters · filed 2023-03-16 | $16.91M derived: sum of 3 quarters · filed 2023-03-16 | $21.81M 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $5.49M 10-Q · filed 2022-11-14 | $11.11M derived: sum of 2 quarters · filed 2022-11-14 | $16.01M 10-Q · filed 2022-11-14 | $19.60M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-06-30 | $5.62M 10-Q · filed 2022-08-15 | $10.52M 10-Q · filed 2022-08-15 | $14.11M derived: sum of 3 quarters · filed 2023-03-16 | $17.18M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-03-31 | $4.90M 10-Q · filed 2022-05-12 | $8.49M derived: sum of 2 quarters · filed 2023-03-16 | $11.56M derived: sum of 3 quarters · filed 2023-03-16 | ||||
| 2020-12-31 | $3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $6.65M derived: sum of 2 quarters · filed 2023-03-16 | $11.73M 10-K · filed 2023-03-16 | ||||
| 2020-09-30 | $3.07M 10-Q · filed 2021-11-15 | $8.15M 10-Q · filed 2021-11-15 | |||||
| 2019-12-31 | $6.41M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |